Hengrui Shares Jump on GSK Deal Worth Up To $12 Billion Bloomberg GSK’s $500M Mega-Deal Unlocks 12 New Medicines: Major COPD Breakthrough in Pipeline Stock Titan Jiangsu Hengrui Pharma stock spikes 10% to 4-year high on drug development deal with GSK – here’s what the company does Mint GSK pays $500M upfront for rights to series of Hengrui drugs statnews.com GSK strengthens COPD offering …
Read More »